There are a number of therapeutics and drugs in phase 3 clinical trials for Alzheimer’s disease. In this conversation Meg Smith, Senior Vice President of Research Management for Cure Alzheimer’s Fund, and Dr. Rudy Tanzi, Chair of the Cure Alzheimer’s Fund Research Leadership Group, discuss the related details of several of these trials. Click the arrow below to view the video.

Share: